Based on the three phases of hemostasis, the development of a hemostatic plug is the result of which phase in the hemostatic system:
Common causes of a bleed during the platelet phase include:
Twelve circulating plasma proteins, (also termed plasma coagulation factors) are found in which pathways:
Which plasma coagulation factor is non-existent in the coagulation phase?
Which plasma coagulation factors are Vitamin K-dependent and pharmacologically (anti-coagulants) depressed by indirect means?
Factor VII is located in which of the following pathways?
Which blood laboratory test monitors patients on warfarin therapy?
Which blood laboratory test monitors patients on heparin therapy and assess defects in the intrinsic pathway of the coagulation system?
Patients with a platelet count of less than ____________ manifest thrombocytopenia.
Which of the following ranges is recommended for “low intensity” Warfarin therapy?
“High intensity” Warfarin therapy (2.5-3.5) is indicated for which of the following conditions?
Aspirin and aspirin-containing drugs exert their anti-thrombotic action by irreversibly inhibiting which of the following hemostatic components?
Based on a literature review by Armenian et al., it is recommended that patients who fall “within the therapeutic range of an INR of _________ or below, warfarin therapy need not be modified or altered for simple single dental extractions.”
Inherited blood coagulation disorders include all of the following, EXCEPT:
Patients with hemophilia B have varying degrees of which of the following plasma coagulation factor deficiencies?
Two defects exist in patients with von Willebrand’s disease, affecting normal hemostasis and resulting in a potential clinical bleed. Which of the following components comprise of this hemorrhagic condition?
Which stringy, insoluble protein is responsible for tightly binding the platelet plug to form the hemostatic clot?
Which common oral manifestation is present as tiny purple or red, 1 to 2 mm spots that appear as a result of minute hemorrhages?
When taking low-dose aspirin (40 to 320 mg) during invasive dental procedures, it is recommended patients _______________ before routine dental extractions or its equivalent procedure.
When considering a local hemostatic agent to control a clinical bleed during invasive procedures, which of the following is NOT an appropriate choice for patients with a bleeding disorder?